Short onset of action of a serotonin reuptake inhibitor when used to reduce premenstrual irritability (Q46505768)

22 December 2017

title

Short onset of action of a serotonin reuptake inhibitor when used to reduce premenstrual irritability (English)

1 reference

22 December 2017

0 references

1

1 reference

22 December 2017

author name string

Helena Erlandsson

2

1 reference

22 December 2017

Finn Bengtsson

3

1 reference

22 December 2017

Björn Andersch

4

1 reference

22 December 2017

Elias Eriksson

5

1 reference

22 December 2017

language of work or name

English

0 references

publication date

2 July 2008

1 reference

22 December 2017

published in

Neuropsychopharmacology

1 reference

22 December 2017

volume

34

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

585-592

1 reference

22 December 2017

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Sertraline in stroke-associated lability of mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Characterizing the effects of sertraline in post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Effect of clomipramine on premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Cortisol, prolactin, growth hormone and neurovegetative responses to emotions elicited during an hypnoidal state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Behavioral indications for serotonin receptor hypersensitivity in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Selective alteration of personality and social behavior by serotonergic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

How does premenstrual dysphoric disorder relate to depression and anxiety disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Effect of fenfluramine on mood: a double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Paroxetine versus citalopram treatment of pathological crying after brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Rapid response of emotional incontinence to selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Therapeutic and adverse actions of serotonin transporter substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Fluoxetine as a treatment for emotional lability after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

Fenfluramine provocation of anxiety in patients with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

The effects of intravenous clomipramine on neurohormones in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

7 January 2021

Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

7 January 2021

Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

7 January 2021

Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

7 January 2021

Impulsive Aggressive Behavior

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

7 January 2021

Rapid simple high-performance liquid chromatographic determination of paroxetine in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

7 January 2021

Symptom-onset treatment for women with premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.86

7 January 2021

Identifiers

DOI

10.1038/NPP.2008.86

1 reference

22 December 2017

1 reference

22 December 2017